期刊文献+

肝脏手术后肺动脉栓塞的危险因素分析和防治体会 被引量:1

下载PDF
导出
摘要 目的分析肝脏手术后发生肺栓塞的危险因素和总结防治经验。方法肝脏术后发生肺栓塞17例为病例组,选同期资料相匹配的17例未发生肺栓塞者作为对照组,采用单因素和多因素分析法比较两组间临床资料的差异。结果单因素分析示,深静脉血栓病(DVT)史、大块肝切除术、术后使用止血药物、术后卧床时间>3d等因素与肝脏术后发生肺栓塞有关(P<0.05);多因素Logistic回归分析示,下肢静脉血栓病史、术后卧床时间>3d是肝脏手术后发生肺栓塞的独立危险因素(P<0.05)。17例肺栓塞患者经溶栓或抗凝治疗后均治愈。结论肝脏手术后发生肺栓塞的主要危险因素是,DVT、术后卧床时间>3d,抗凝是防治肺栓塞的有效措施。
出处 《福建医药杂志》 CAS 2015年第3期24-26,共3页 Fujian Medical Journal
  • 相关文献

参考文献4

  • 1急性肺血栓栓塞症诊断治疗中国专家共识[J].中华内科杂志,2010,49(1):74-81. 被引量:401
  • 2李旭,范隆华,沈卫星,刘坚军,徐德春.腹部手术后急性肺栓塞的预防和治疗[J].中华普通外科杂志,2013,28(12):948-951. 被引量:5
  • 3Aslam E, Gaya S:Yuhree K, et al. Defining incidence and risk factors of venous thromboemolism after hepatectomy [J]. J Gas- trointest Surg, 2014, 18 (6): 1116-1124.
  • 4Jaff M R, McMurtry M S, Archer S L, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembulic pulmonary hyper- tension : a scientific statement from the American Heart Associa- tion [J]. Circulation, 2011, 123 (16): 1788-1830.

二级参考文献53

  • 1荆志成,邓可武.急性肺动脉血栓栓塞症的溶栓治疗[J].中华医学杂志,2004,84(22):1932-1934. 被引量:20
  • 2邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 3Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatnlent of major pulmonary embolism. Ann Thorae Surg, 2004,77:819-823.
  • 4Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev, 2005, 19 : 179-202.
  • 5PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d' Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 2005,112:416-422.
  • 6Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients : an AAST multicenter study. J Trauma, 2007,62 : 17-24.
  • 7Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino) , 2008,49:35-49.
  • 8Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : a European nmlticenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239-245.
  • 9Dalla-Volta S, Palla A, Santolicandro A, et al. PALMS 2: aheplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 1992, 20:520-526.
  • 10Levine M, Hirsh J, Weitz J, et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest, 1990, 98: 1473-1479.

共引文献404

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部